Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Mathieu Uzzan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology Department, Fédération Hosp…. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Crohn Disease, Patient Selection, Colitis, Ulcerative. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction
While recruitment rates in inflammatory bowel disease (IBD) trials are continuously decreasing, the underlying reasons are likely multifactorial but remain poorly defined. Screen failure (SF) proportions and causes have not been extensively explored in IBD.
Aim
We assessed SF proportions and underlying SF reasons in IBD phase 2 and 3 clinical trials.
Methods
We analyzed SF-related data from 17 randomized controlled phase 2 or 3 IBD trials. Twelve trials were in ulcerative colitis (UC) and 5 trials were in Crohn’s disease (CD) operated by a single contract research organization, IQVIA. Differences between patient groups were tested for significance by Mann-Whitney and Fisher’s tests when appropriate.
Results
We analyzed a total of 11 161 patients with UC and 5752 patients with CD. The mean SF proportion was 0.43 per trial in UC. The primary reason for SFs in UC was not meeting the overall (modified) Mayo score inclusion threshold and/or the endoscopic subscore of at least 2 (33.8% of all SF). In CD clinical trials, the mean SF proportion was at 0.53. The primary cause for SFs was not meeting the CDAI eligibility criteria (23.1% of all SFs). SF proportions were significantly higher in CD versus UC trials (P = .027). Clostridium difficile or any other intestinal infection and not meeting tuberculosis screening criteria were other major reasons for SFs both in UC and CD.
Conclusion
High SF proportion in IBD clinical trials, particularly for CD studies, pose obstacles to patient recruitment. While underlying causes are diverse, arbitrarily defined clinical and/or endoscopic eligibility criteria remain the major limiting factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology Department, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Crét…
- IQVIA, IBD Department, Sofia, Bulgaria.
- Department of Gastroenterology, Nancy University Hospital Inserm NGERE U1256, Lorraine University, Vandoeuvre-Les-Nancy, France.
- Paris IBD Center, Groupe Hospitalier Privé Ambroise Paré-Hartmann, Neuilly-sur-Seine, France.
- Division of Gastroenterology, Department of Medicine, Farncombe Family Digestive Health Research Institute, Hamilton, ON, Canada.
- McMaster University, Hamilton, ON, Canada.
ORCID-Profile: Mathieu Uzzan, Ryan Ungaro, Johan Burisch, Walter Reinisch
Zitieren
APA
Uzzan, M., Georgiev, G., Peyrin-Biroulet, L., Bouhnik, Y., Narula, N., Jairath, V., Ungaro, R., Burisch, J., Kirchgesner, J., Verstockt, B., Hussain, F., & Reinisch, W. (2025). Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae233
Vancouver
Uzzan M, Georgiev G, Peyrin-Biroulet L, Bouhnik Y, Narula N, Jairath V, et al. Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae233
BibTeX
@article{Uzzan2025,
author = {Uzzan, Mathieu and Georgiev, Georgi and Peyrin-Biroulet, Laurent and Bouhnik, Yoram and Narula, Neeraj and Jairath, Vipul and Ungaro, Ryan and Burisch, Johan and Kirchgesner, Julien and Verstockt, Bram and Hussain, Fez and Reinisch, Walter},
title = {Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae233}
}
EUVIMED